Education
About Us
Working with TipRanks
Follow Us
Viemed Healthcare US (VMD)
NASDAQ:VMD
VMD Stock Chart & Stats
$6.88
$0.08(0.94%)
At close: 4:00 PM EST
$6.88
$0.08(0.94%)
Day’s Range― - ―
52-Week Range$5.93 - $10.06
Previous CloseN/A
Volume27.16K
Average Volume (3M)308.48K
Market Cap
$336.23M
Enterprise Value$356.82M
Total Cash (Recent Filing)$13.50M
Total Debt (Recent Filing)$15.95M
Price to Earnings (P/E)19.4
Beta0.73
Next Earnings
May 11, 2026EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.14
Shares Outstanding38,602,630
10 Day Avg. Volume532,659
30 Day Avg. Volume308,477
Financial Highlights & Ratios
PEG Ratio0.62
Price to Book (P/B)2.04
Price to Sales (P/S)1.07
P/FCF Ratio24.22
Enterprise Value/Market Cap1.06
Enterprise Value/Revenue1.32
Enterprise Value/Gross Profit2.32
Enterprise Value/Ebitda6.86
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.47
Revenue Forecast (FY)$332.55M
Bulls Say, Bears Say
Bulls Say
Revenue Diversification & Patient GrowthRapid expansion in sleep, PATH therapy and resupply materially diversifies Viemed’s revenue mix beyond core ventilator rentals. These high-growth, recurring service lines increase patient lifetime value, reduce single-segment concentration, and provide durable recurring revenue as chronic-care adoption and resupply needs persist.
Strong Operating Cash GenerationConsistent and improving operating cash flow supports reinvestment, capex guidance (~10–11.5% of revenue), buybacks and M&A without relying on heavy external financing. Durable cash generation strengthens financial resilience and funds execution of growth initiatives over the next several quarters.
Conservative Leverage And LiquidityA modest debt load and substantial available credit give Viemed financial flexibility to absorb regulatory transitions, pursue tuck-in acquisitions, and sustain capex and working-capital needs. Low leverage reduces solvency risk and preserves optionality for capital allocation decisions over the medium term.
Bears Say
Regulatory Transition (NCD) DragThe updated national coverage determination reduces the eligible ventilator patient pool and raises documentation requirements, creating persistent headwinds to ventilator unit growth. Higher compliance effort increases operating cost and physician-education needs, potentially slowing topline growth in that segment for several quarters.
Margin Volatility / EBITDA PressureWhile gross margins remain healthy, operating and EBITDA margins showed a notable step-down in 2025 and free cash flow has been volatile. Dependence on occasional non-recurring gains and uneven margin performance raises the risk that profitability will not expand in lockstep with revenue without sustained operational leverage.
Execution Risk Scaling Maternal HealthMaternal-health expansion is strategically promising but requires complex payer contracting, state-level reimbursement work, field sales and fulfillment scale-up. These operational and regulatory tasks are resource-intensive and can strain margins or slow rollout if execution and payor acceptance lag the company’s timeline.
Viemed Healthcare News
VMD FAQ
What was Viemed Healthcare US’s price range in the past 12 months?
Viemed Healthcare US lowest stock price was $5.93 and its highest was $10.06 in the past 12 months.
What is Viemed Healthcare US’s market cap?
Viemed Healthcare US’s market cap is $336.23M.
When is Viemed Healthcare US’s upcoming earnings report date?
Viemed Healthcare US’s upcoming earnings report date is May 11, 2026 which is in 48 days.
How were Viemed Healthcare US’s earnings last quarter?
Viemed Healthcare US released its earnings results on Mar 04, 2026. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.125 by $0.015.
Is Viemed Healthcare US overvalued?
According to Wall Street analysts Viemed Healthcare US’s price is currently Overvalued.
Does Viemed Healthcare US pay dividends?
Viemed Healthcare US does not currently pay dividends.
What is Viemed Healthcare US’s EPS estimate?
Viemed Healthcare US’s EPS estimate is 0.09.
How many shares outstanding does Viemed Healthcare US have?
Viemed Healthcare US has 38,602,630 shares outstanding.
What happened to Viemed Healthcare US’s price movement after its last earnings report?
Viemed Healthcare US reported an EPS of $0.14 in its last earnings report, beating expectations of $0.125. Following the earnings report the stock price went down -7.489%.
Which hedge fund is a major shareholder of Viemed Healthcare US?
Currently, no hedge funds are holding shares in VMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Viemed Healthcare Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
VMD Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 40.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 7.5%
Last 30 Days ▼ 7.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
18.34%
12-Months-Change
Fundamentals
Return on Equity
10.87%
Trailing 12-Months
Asset Growth
21.39%
Trailing 12-Months
Company Description
Viemed Healthcare US
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
VMD Company Deck
VMD Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a predominantly positive outlook: Viemed delivered record revenue and adjusted EBITDA, materially improved free cash flow, diversified its revenue mix with strong growth in sleep and resupply, and closed an accretive maternal health acquisition. The company acknowledges near-term headwinds from the implementation of the updated NCD—causing short-term moderation in ventilator growth, additional compliance effort, and an expected flat Q1 cadence—but emphasizes that these are transition-related and that early 2026 signals (strong January vent setups, ALJ appeals success) indicate improvement. Financial position (low net leverage, liquidity) and a disciplined capital allocation plan (including buybacks) underpin confidence in the growth plan, making the positives outweigh the transition-related negatives.View all VMD earnings summariesTechnical Analysis
Ownership Overview
13.98% Insiders
13.09% Mutual Funds
22.48% Other Institutional Investors
42.63% Public Companies and
Individual Investors